We look to you as our partners as we collectively learn more about SCN2A and its effects on patients and their families. We will regularly share new studies, new information, and potential opportunities to get involved.
SCN2A Parent Survey
We want to learn from parents of children with mutations in the SCN2A gene. By taking our 15-minute anonymous survey, you will help inform our research efforts to develop novel therapies for SCN2A. The results will be shared with the SCN2A community.Take the Survey
SCN2A Natural History Study
Learn how you can make a significant difference in the SCN2A community and help focus future drug development.Learn More
Drug Development Programs
Praxis is currently developing potential new treatments for children with genetic epilepsies caused by gain-of-function mutations in SCN2A, SCN8A, and other indications.Learn More